Search Results 2071-2080 of 17641 for Mindful Birth Control
... Controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium ...
... management of prostate cancer. Exclusion Criteria: Patients who already received primary treatment or neo-adjuvant therapy. Patients who refuse undergoing ...
Asthma and currently on steroid to control disease. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...
This is a placebo and active-controlled phase 2b dose-finding study to evaluate efficacy and safety of QGE031 monthly subcutaneous injections as add-on ...
The purpose of this study is to compare radiation dermatitis severity in irradiated skin protected by an agent versus uncovered skin (internal control) based on ...
Kristina A. Butler, M.D., M.S. · Gynecologic Oncologist · Gynecologist.
Wu SY, Parker B, Cunningham C, Shah S, Wannamaker EJ, Pham MD. Splenic and multifocal renal infarcts as a rare presentation of hereditary hemorrhagic ...
Pancreatic Cancer/Postpartum Depression/Population Health Management: Mayo Clinic Radio. According to the National Cancer Institute, by the end of this year ...
Gupta S, Dasari S, Shen W, Kipp BR, Erickson LA, Cheville JC. Insights from single cell and bulk RNA sequencing: increased NOTCH signaling is correlated ...
An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20465150.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!